PDA is pleased to announce the results of the 2012 Board of Directors and Officers election. The elected candidates will fill their term beginning on January 1, 2012. Thank you to all who voted!
Anders Vinther, PhD, VP, Head Quality Biologics at Genentech, was elected in 2010 to the Chair-elect position and will serve as Chair from January 2012 through 2014. Harold Baseman, Principal and Chief Operating Officer for ValSource, has been elected as the Chair-Elect, Steven Mendivil, Executive Director of Corporate Quality External Affairs for Amgen, Inc.has been elected as the Secretary and Rebecca Devine, PhD, Regulatory Consultant, has been elected as Treasurer.
Maik Jornitz, Senior Vice President, Marketing Bioprocess Sartorius Stedim North America, has become the immediate past chair and will serve in that position for two more years.
The PDA Board of Directors welcomes Ursula Busse, PhD, MBA, Head of Project Office for Biopharmaceutical Operations at Novartis, John Finkbohner, PhD, Senior Director of Regulatory Affairs at MedImmune. Re-elected Board members areJunko Sasaki, Quality Assurance Principal, Dainippon Sumitomo Pharma. Co., Ltd. and Christopher Smalley, PhD, Associate Director, Merck & Company.
PDA would like to extend a sincere thank you to John Shabushnig PhD, Sr. Manager/Team Leader, Quality Systems and Technical Services, Pfizer, and Amy Scott-Billman, Head, Worldwide Regulatory Strategy, Cancer Immunotherapeutics GlaxoSmithKline for their years of service on the Board of Directors.
More information is available in the January issue of the PDA Letter.